4//SEC Filing
Davis Blaine 4
Accession 0001453687-25-000035
CIK 0001453687other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 8:04 PM ET
Size
6.3 KB
Accession
0001453687-25-000035
Insider Transaction Report
Form 4
Davis Blaine
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-01-03$16.72/sh−3,961$66,235→ 98,839 total - Sale
Common Stock
2025-01-06$16.83/sh−4,028$67,800→ 94,811 total
Footnotes (1)
- [F1]Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.
Documents
Issuer
Cartesian Therapeutics, Inc.
CIK 0001453687
Entity typeother
Related Parties
1- filerCIK 0001802188
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 8:04 PM ET
- Size
- 6.3 KB